9th Dec 2021 7:00 am |
RNS |
4D pharma presents IBS Phase 2 microbiome analysis |
7th Dec 2021 2:19 pm |
RNS |
Holding(s) in Company |
19th Nov 2021 5:58 pm |
RNS |
Holding(s) in Company |
11th Nov 2021 7:00 am |
RNS |
4D pharma Jefferies Healthcare Conference |
12th Oct 2021 7:00 am |
RNS |
Jefferies Next Generation IBD Therapeutics Summit |
30th Sep 2021 7:00 am |
RNS |
Half-year Report |
16th Sep 2021 2:08 pm |
RNS |
Holding(s) in Company |
15th Sep 2021 7:00 am |
RNS |
4D pharma presents two posters at ESMO Congress |
9th Sep 2021 7:00 am |
RNS |
Participation in Upcoming Investor Conferences |
19th Aug 2021 9:44 am |
RNS |
Holding(s) in Company |
2nd Aug 2021 7:00 am |
RNS |
Two MRx0518 presentations accepted for ESMO 2021 |
29th Jul 2021 7:00 am |
RNS |
$30 Million Credit Facility with Oxford Finance |
26th Jul 2021 1:00 pm |
RNS |
Passing of Chief Financial Officer John Beck |
6th Jul 2021 7:00 am |
RNS |
Publication - LBP improves activity of CAR-T |
29th Jun 2021 7:00 am |
RNS |
Ladenburg Thalmann Healthcare Conference |
22nd Jun 2021 7:00 am |
RNS |
Conference presentation on LBP Manufacturing’ |
4th Jun 2021 7:00 am |
RNS |
Asthma trial Part A enrolment and program update |
1st Jun 2021 8:52 am |
RNS |
Total Voting Rights |
24th May 2021 10:48 am |
RNS |
Result of AGM |
24th May 2021 7:00 am |
RNS |
Update on Data for Phase II Study of Blautix |
17th May 2021 7:00 am |
RNS |
Presentation of Blautix IBS Phase II at DDW 2021 |
19th Apr 2021 7:00 am |
RNS |
Collaboration with Parkinson’s UK |
16th Apr 2021 7:00 am |
RNS |
Directors’ Subscription for new Ordinary Shares |
15th Apr 2021 5:00 pm |
RNS |
Annual Financial Report |
15th Apr 2021 7:00 am |
RNS |
Participation in Jefferies Therapeutics Summit |
12th Apr 2021 2:26 pm |
RNS |
Holding(s) in Company |
7th Apr 2021 7:00 am |
RNS |
How to Convert AIM Ordinary Shares into Nasdaq ADS |
1st Apr 2021 7:00 am |
RNS |
Final Results |
26th Mar 2021 3:21 pm |
RNS |
Holding(s) in Company |
25th Mar 2021 12:08 pm |
RNS |
Holding(s) in Company |
25th Mar 2021 8:00 am |
RNS |
Holding(s) in Company |
22nd Mar 2021 7:00 am |
RNS |
Completion of Merger |
18th Mar 2021 1:25 pm |
RNS |
Result of Meeting |
17th Mar 2021 1:00 pm |
RNS |
4D Pharma Announces Private Placement |
3rd Mar 2021 7:00 am |
RNS |
Investor conference participation |
1st Mar 2021 5:49 pm |
RNS |
Exercise of Options and Total Voting Rights |
1st Mar 2021 7:02 am |
RNS |
John Beck Appointed as Chief Financial Officer |
1st Mar 2021 7:00 am |
RNS |
Appoints Paul Maier to the Board as NED |
26th Feb 2021 12:52 pm |
RNS |
Holding(s) in Company |
26th Feb 2021 7:02 am |
RNS |
Posting of Circular |